Literature DB >> 18488199

Protection of the right ventricle from ischemia and reperfusion by preceding hypoxia.

Daniela Wasserfuhr1, Sürreya M Cetin, Jun Yang, Patricia Freitag, Stilla Frede, Heinz Jakob, Parwis Massoudy.   

Abstract

We have previously shown that 2 weeks of hypoxia protect the right ventricle of the rat heart from subsequent ischemia and reperfusion (I/R). In the present study, we examined the following: (1) Do shorter periods of hypoxia protect from subsequent I/R? (2) Does intermittent normoxia increase the cardioprotective effect? (3) Is hypoxia-inducible factor-1alpha (HIF-1alpha), erythropoietin (EPO), or vascular endothelial growth factor (VEGF) involved in the protective effects? Preischemic cardiac work was followed by global ischemia, reperfusion, and postischemic cardiac work (15 min each). External heart work was determined at the end of both work phases. Four groups of hearts were investigated: hearts from normoxic rats (n=8), hearts from rats after 24 h of continuous hypoxia (10.5% inspired oxygen, n=7), hearts from rats after 24 h hypoxia with a single intermission of 30 min normoxia (n=9), and hearts from rats after 24 h hypoxia and multiple intermissions of 30 min normoxia (n=7). Protein levels of HIF-1alpha and mRNA levels of EPO and VEGF were determined in right ventricular tissue of normoxic and hypoxic hearts. Postischemic right heart recovery was better in all three hypoxic groups compared with normoxic hearts (61.8 +/- 5.9%, 65.6 +/- 3.0%, and 75.7 +/- 2.6% vs. 46.0 +/- 3.9%, p < 0.01). Hypoxia with multiple normoxic intermissions further improved right heart recovery compared to continuous hypoxia (p < 0.05). HIF-1alpha protein levels were 80.3 +/- 2.5 pg/microg in normoxic hearts and 108.0 +/- 10.3 pg/microg in hypoxic hearts (p = 0.02). No differences in EPO and VEGF mRNA levels were found between normoxic and hypoxic hearts. Twenty-four hours of continuous hypoxia protect the isolated working right heart from subsequent ischemia and reperfusion. When preceding hypoxia is interrupted by multiple reoxygenation periods, there is a further significant increase in cardiac functional recovery. HIF-1alpha may be involved in the protective effect.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18488199     DOI: 10.1007/s00210-008-0303-x

Source DB:  PubMed          Journal:  Naunyn Schmiedebergs Arch Pharmacol        ISSN: 0028-1298            Impact factor:   3.000


  11 in total

1.  Late preconditioning against myocardial stunning. Does aspirin close the "second window" of endogenous cardioprotection?

Authors:  Karin Przyklenk; Gerd Heusch
Journal:  J Am Coll Cardiol       Date:  2003-04-02       Impact factor: 24.094

2.  Blood-perfused working isolated rat heart.

Authors:  M A Duvelleroy; M Duruble; J L Martin; B Teisseire; J Droulez; M Cain
Journal:  J Appl Physiol       Date:  1976-10       Impact factor: 3.531

3.  Single-step method of RNA isolation by acid guanidinium thiocyanate-phenol-chloroform extraction.

Authors:  P Chomczynski; N Sacchi
Journal:  Anal Biochem       Date:  1987-04       Impact factor: 3.365

4.  Chronic and intermittent hypoxia induce different degrees of myocardial tolerance to hypoxia-induced dysfunction.

Authors:  Giuseppina Milano; Antonio F Corno; Silvio Lippa; Ludwig K Von Segesser; Michele Samaja
Journal:  Exp Biol Med (Maywood)       Date:  2002-06

5.  Increased tolerance of the chronically hypoxic immature heart to ischemia. Contribution of the KATP channel.

Authors:  J E Baker; B D Curry; G N Olinger; G J Gross
Journal:  Circulation       Date:  1997-03-04       Impact factor: 29.690

6.  Erythropoietin protects the myocardium against reperfusion injury in vitro and in vivo.

Authors:  A J Bullard; P Govewalla; D M Yellon
Journal:  Basic Res Cardiol       Date:  2005-06-10       Impact factor: 17.165

7.  Acute intermittent hypoxia improves rat myocardium tolerance to ischemia.

Authors:  P C Béguin; M Joyeux-Faure; D Godin-Ribuot; P Lévy; C Ribuot
Journal:  J Appl Physiol (1985)       Date:  2005-05-05

8.  Responses of chronically hypoxic rat hearts to ischemia: KATP channel blockade does not abolish increased RV tolerance to ischemia.

Authors:  Joerg Forkel; Xiaochao Chen; Susanne Wandinger; Florian Keser; Alexey Duschin; Uwe Schwanke; Stilla Frede; Parwis Massoudy; Rainer Schulz; Heinz Jakob; Gerd Heusch
Journal:  Am J Physiol Heart Circ Physiol       Date:  2003-10-09       Impact factor: 4.733

9.  Nitric oxide accounts for postischemic cardioprotection resulting from angiotensin-converting enzyme inhibition: indirect evidence for a radical scavenger effect in isolated guinea pig heart.

Authors:  P Massoudy; B F Becker; E Gerlach
Journal:  J Cardiovasc Pharmacol       Date:  1995-03       Impact factor: 3.105

10.  Hearts from rodents exposed to intermittent hypoxia or erythropoietin are protected against ischemia-reperfusion injury.

Authors:  Zheqing Cai; Dominador J Manalo; Guo Wei; E Rene Rodriguez; Karen Fox-Talbot; Huasheng Lu; Jay L Zweier; Gregg L Semenza
Journal:  Circulation       Date:  2003-06-09       Impact factor: 29.690

View more
  2 in total

Review 1.  Hypoxia inducible factor 1 (HIF-1) and cardioprotection.

Authors:  Demet Tekin; Ali D Dursun; Lei Xi
Journal:  Acta Pharmacol Sin       Date:  2010-08-16       Impact factor: 6.150

2.  Hypoxia preconditioning protection of corneal stromal cells requires HIF1alpha but not VEGF.

Authors:  Dongmei Xing; Joseph A Bonanno
Journal:  Mol Vis       Date:  2009-05-18       Impact factor: 2.367

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.